Identification of Functional TFAP2A and SP1 Binding Sites in New TFAP2A-modulated Genes

Overview

Journal BMC Genomics

Publisher Biomed Central

Specialty Genetics

Date 2010 Jun 8

PMID 20525283

Citations 18

Authors

Francesca Orso

Davide Cora

Benedetta Ubezio

Paolo Provero

Michele Caselle

Daniela Taverna

Affiliations

Soon will be listed here.

Abstract

Background: Different approaches have been developed to dissect the interplay between transcription factors (TFs) and their cis-acting sequences on DNA in order to identify TF target genes. Here we used a combination of computational and experimental approaches to identify novel direct targets of TFAP2A, a key TF for a variety of physiological and pathological cellular processes. Gene expression profiles of HeLa cells either silenced for TFAP2A by RNA interference or not were previously compared and a set of differentially expressed genes was revealed.

Results: The regulatory regions of 494 TFAP2A-modulated genes were analyzed for the presence of TFAP2A binding sites, employing the canonical TFAP2A Positional Weight Matrix (PWM) reported in Jaspar http://jaspar.genereg.net/. 264 genes containing at least 2 high score TFAP2A binding sites were identified, showing a central role in "Cellular Movement" and "Cellular Development". In an attempt to identify TFs that could cooperate with TFAP2A, a statistically significant enrichment for SP1 binding sites was found for TFAP2A-activated but not repressed genes. The direct binding of TFAP2A or SP1 to a random subset of TFAP2A-modulated genes was demonstrated by Chromatin ImmunoPrecipitation (ChIP) assay and the TFAP2A-driven regulation of DCBLD2/ESDN/CLCP1 gene studied in details.

Conclusions: We proved that our computational approaches applied to microarray selected genes are valid tools to identify functional TF binding sites in gene regulatory regions as confirmed by experimental validations. In addition, we demonstrated a fine-tuned regulation of DCBLD2/ESDN transcription by TFAP2A.

Citing Articles

Polymorphisms of and Genes and Their Effects on Milk Production Traits in Chinese Holstein Cows.

Chen A, Yang Q, Ye W, Xu L, Wang Y, Sun D Animals (Basel). 2024; 14(9).

PMID: 38731280 PMC: 11083613. DOI: 10.3390/ani14091276.

Macroscopic inhibition of DNA damage repair pathways by targeting AP-2α with LEI110 eradicates hepatocellular carcinoma.

Wang C, Zhao Z, Zhao Y, Zhao J, Xia L, Xia Q Commun Biol. 2024; 7(1):342.

PMID: 38503825 PMC: 10951303. DOI: 10.1038/s42003-024-05939-7.

TFAP2A promotes cervical cancer via a positive feedback pathway with PD‑L1.

Yang J, Gao Y, Yao S, Wan S, Cai H Oncol Rep. 2023; 49(6).

PMID: 37083077 PMC: 10170487. DOI: 10.3892/or.2023.8551.

A unique Smith-Magenis patient with a de novo intragenic deletion on the maternally inherited overexpressed RAI1 allele.

Sironi A, Bestetti I, Masciadri M, Tumiatti F, Crippa M, Pantaleoni C Eur J Hum Genet. 2022; 30(11):1233-1238.

PMID: 35821519 PMC: 9626456. DOI: 10.1038/s41431-022-01143-5.

Determination of WWOX Function in Modulating Cellular Pathways Activated by AP-2α and AP-2γ Transcription Factors in Bladder Cancer.

Kolat D, Kaluzinska Z, Bednarek A, Pluciennik E Cells. 2022; 11(9).

PMID: 35563688 PMC: 9106060. DOI: 10.3390/cells11091382.

References

Jolly E, Chin C, Herskowitz I, Li H . Genome-wide identification of the regulatory targets of a transcription factor using biochemical characterization and computational genomic analysis. BMC Bioinformatics. 2005; 6:275. PMC: 1326232. DOI: 10.1186/1471-2105-6-275. View

Zhao F, Satoda M, Licht J, Hayashizaki Y, Gelb B . Cloning and characterization of a novel mouse AP-2 transcription factor, AP-2delta, with unique DNA binding and transactivation properties. J Biol Chem. 2001; 276(44):40755-60. DOI: 10.1074/jbc.M106284200. View

Wang H, Vaupel K, Buettner R, Bosserhoff A, Moser M . Identification and embryonic expression of a new AP-2 transcription factor, AP-2 epsilon. Dev Dyn. 2004; 231(1):128-35. DOI: 10.1002/dvdy.20119. View

Ding X, Fan C, Zhou J, Zhong Y, Liu R, Ren K . GAS41 interacts with transcription factor AP-2beta and stimulates AP-2beta-mediated transactivation. Nucleic Acids Res. 2006; 34(9):2570-8. PMC: 3303177. DOI: 10.1093/nar/gkl319. View

McPherson L, Weigel R . AP2alpha and AP2gamma: a comparison of binding site specificity and trans-activation of the estrogen receptor promoter and single site promoter constructs. Nucleic Acids Res. 1999; 27(20):4040-9. PMC: 148672. DOI: 10.1093/nar/27.20.4040. View

Eckert D, Buhl S, Weber S, Jager R, Schorle H . The AP-2 family of transcription factors. Genome Biol. 2006; 6(13):246. PMC: 1414101. DOI: 10.1186/gb-2005-6-13-246. View

Mertens P, Steinmann K, Lovett D . A synergistic interaction of transcription factors AP2 and YB-1 regulates gelatinase A enhancer-dependent transcription. J Biol Chem. 1998; 273(49):32957-65. DOI: 10.1074/jbc.273.49.32957. View

Bouvet P . Identification of nucleic acid high-affinity binding sequences of proteins by SELEX. Methods Mol Biol. 2009; 543:139-50. DOI: 10.1007/978-1-60327-015-1_11. View

Mohibullah N, Donner A, Ippolito J, Williams T . SELEX and missing phosphate contact analyses reveal flexibility within the AP-2[alpha] protein: DNA binding complex. Nucleic Acids Res. 1999; 27(13):2760-9. PMC: 148486. DOI: 10.1093/nar/27.13.2760. View

10.

Stormo G . DNA binding sites: representation and discovery. Bioinformatics. 2000; 16(1):16-23. DOI: 10.1093/bioinformatics/16.1.16. View

11.

Gee M, Sarkisian C, El-Deiry W . Identification of a novel AP-2 consensus DNA binding site. Biochem Biophys Res Commun. 1998; 243(1):307-16. DOI: 10.1006/bbrc.1997.8035. View

12.

Boutros T, Chevet E, Metrakos P . Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase regulation: roles in cell growth, death, and cancer. Pharmacol Rev. 2008; 60(3):261-310. DOI: 10.1124/pr.107.00106. View

13.

Cora D, Herrmann C, Dieterich C, Di Cunto F, Provero P, Caselle M . Ab initio identification of putative human transcription factor binding sites by comparative genomics. BMC Bioinformatics. 2005; 6:110. PMC: 1097714. DOI: 10.1186/1471-2105-6-110. View

14.

Scharer C, McCabe C, Ali-Seyed M, Berger M, Bulyk M, Moreno C . Genome-wide promoter analysis of the SOX4 transcriptional network in prostate cancer cells. Cancer Res. 2009; 69(2):709-17. PMC: 2629396. DOI: 10.1158/0008-5472.CAN-08-3415. View

15.

Cha B, Shi W, Yonezawa T, Teruya T, Nagai K, Woo J . An inhibitory effect of chrysoeriol on platelet-derived growth factor (PDGF)-induced proliferation and PDGF receptor signaling in human aortic smooth muscle cells. J Pharmacol Sci. 2009; 110(1):105-10. DOI: 10.1254/jphs.08282fp. View

16.

Yin T, Yang Y . Mitogen-activated protein kinases and ribosomal S6 protein kinases are involved in signaling pathways shared by interleukin-11, interleukin-6, leukemia inhibitory factor, and oncostatin M in mouse 3T3-L1 cells. J Biol Chem. 1994; 269(5):3731-8. View

17.

Werling U, Schorle H . Transcription factor gene AP-2 gamma essential for early murine development. Mol Cell Biol. 2002; 22(9):3149-56. PMC: 133770. DOI: 10.1128/MCB.22.9.3149-3156.2002. View

18.

Pollock J, Baule V, Rich C, Ginsburg C, Curtiss S, Foster J . Chick tropoelastin isoforms. From the gene to the extracellular matrix. J Biol Chem. 1990; 265(7):3697-702. View

19.

Sivak J, West-Mays J, Yee A, Williams T, Fini M . Transcription Factors Pax6 and AP-2alpha Interact To Coordinate Corneal Epithelial Repair by Controlling Expression of Matrix Metalloproteinase Gelatinase B. Mol Cell Biol. 2003; 24(1):245-57. PMC: 303332. DOI: 10.1128/MCB.24.1.245-257.2004. View

20.

Salanga C, OHayre M, Handel T . Modulation of chemokine receptor activity through dimerization and crosstalk. Cell Mol Life Sci. 2008; 66(8):1370-86. PMC: 2738873. DOI: 10.1007/s00018-008-8666-1. View